Stay updated on Enhancing Anti PD-1 Therapy by Depleting MDSCs Clinical Trial
Sign up to get notified when there's something new on the Enhancing Anti PD-1 Therapy by Depleting MDSCs Clinical Trial page.

Latest updates to the Enhancing Anti PD-1 Therapy by Depleting MDSCs Clinical Trial page
- Check5 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1.0%
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check27 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check55 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check70 days agoChange DetectedThe webpage has been updated to reflect a new version of a clinical study involving Nivolumab and Gemcitabine for treating Non-Small Cell Lung Cancer Stage IIIB, with specific details on the treatment regimen and study location. The previous version's detailed objectives and criteria for the study have been removed.SummaryDifference48%
- Check77 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Enhancing Anti PD-1 Therapy by Depleting MDSCs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enhancing Anti PD-1 Therapy by Depleting MDSCs Clinical Trial page.